Metabolic signaling
MOTS-C
A mitochondrial-derived peptide studied in metabolic signaling.
Evidence score2/5
Early human evidence
- Evidence
- Preclinical
- Status
- Published
Topic authority hub
Mitochondrial Health
Mitochondrial-derived peptides, mitochondrial targeting, cardiolipin context, redox biology, and metabolic stress signaling.
Research frame
Mitochondrial health is not one mechanism. MOTS-C, SS-31, and NAD+ sit in different research categories: encoded micropeptide signaling, mitochondria-targeted peptide research, and established redox biochemistry.
The hub is designed to make those categories comparable without implying they are interchangeable.
Featured compounds
Metabolic signaling
SS-31
A mitochondria-targeted tetrapeptide indexed in the literature as elamipretide and MTP-131.
Evidence score3/5
Developing clinical evidence
- Evidence
- Mixed translational
- Status
- Published
Metabolic signaling
NAD+
A ubiquitous redox cofactor and substrate in cellular metabolism.
Evidence score5/5
Established evidence base
- Evidence
- Established biochemical
- Status
- Published
Repair & matrix
GHK-Cu
A copper-binding tripeptide complex studied in matrix biology.
Evidence score3/5
Developing clinical evidence
- Evidence
- Mixed translational
- Status
- Published
Featured studies
Grade DReview2015PubMed metadata verified
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.
Verified PubMed record for MOTS-C: The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.
- Journal
- Cell metabolism
- Evidence context
- Metadata-only, mechanistic, or limited evidence
Grade AHuman randomized trial2023PubMed metadata verified
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial.
Verified PubMed record for SS-31: Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial.
- Journal
- Neurology
- Evidence context
- High-level synthesis or controlled evidence
Grade DReview2024PubMed metadata verified
MOTS-c modulates skeletal muscle function by directly binding and activating CK2.
Verified PubMed record for MOTS-C: MOTS-c modulates skeletal muscle function by directly binding and activating CK2.
- Journal
- iScience
- Evidence context
- Metadata-only, mechanistic, or limited evidence
Comparisons
MOTS-C vs. SS-31A structured research comparison between MOTS-C and SS-31 across compound identity, research category, evidence maturity, and interpretation boundaries.MOTS-C vs. NAD+A structured research comparison between MOTS-C and NAD+ across compound identity, research category, evidence maturity, and interpretation boundaries.GHK-Cu vs. TA1A structured research comparison between GHK-Cu and Thymosin Alpha 1 across compound identity, research category, evidence maturity, and interpretation boundaries.
Authority articles
Mitochondrial health
MOTS-C Research Overview
MOTS-C is an authority bridge between mitochondrial-derived peptides, metabolism, aging, and redox biology.
Mitochondrial health
SS-31 Research Overview
SS-31 has enough translational literature to deserve its own hub role, but the evidence is still endpoint- and disease-context dependent.
Peptide research
GHK-Cu Research Overview
GHK-Cu has a deep matrix-biology footprint, but formulation and model boundaries determine what can be claimed.